Biological validation of plant-derived anti-human colorectal cancer monoclonal antibody CO17-1A.

We validated expression and biological activities of plant-derived monoclonal antibody (MAb(P)) CO17-1A for its efficacy in cancer immunotherapy. PCR and immunoblot analyses demonstrated insertion and expression of heavy and light chains of MAb CO17-1A in transgenic plants, respectively. Confocal analysis revealed that MAb(P) CO17-1A was accumulated throughout the cytoplasm near the outer membrane, suggesting its secretion to the outer membrane via a default pathway. Cell ELISA analysis confirmed that the MAb(P) CO17-1A heavy and light chains in crude plant leaf samples assembled to specifically bind SW948 human colorectal carcinoma cells. Flow cytometry analysis showed that the Fc domains of both the purified MAb(P) and the mammalian-derived MAb (MAb(M)) evidenced similar binding activity to the FcgammaRI receptor (CD64). The biological activities of both MAbs were similar, although the glycosylation pattern of MAb(P) CO17-1A is distinct from that of MAb(M). These results point to the potential use of MAb(P) CO17-1A for colorectal cancer immunotherapy.

[1]  M. Glogowska,et al.  Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Lerouge,et al.  Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. , 2004, Plant biotechnology journal.

[3]  A. Helenius,et al.  Intracellular functions of N-linked glycans. , 2001, Science.

[4]  J. Leusen,et al.  The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. , 2006, Cancer research.

[5]  U. K. Laemmli,et al.  Form-determining function of the genes required for the assembly of the head of bacteriophage T4. , 1970, Journal of molecular biology.

[6]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[7]  M. Glogowska,et al.  Inhibition of tumor growth by plant-derived mAb. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Ono,et al.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. , 1996, Nature.

[9]  Pauline M Rudd,et al.  Controlled glycosylation of therapeutic antibodies in plants. , 2004, Archives of biochemistry and biophysics.

[10]  A. Hiatt,et al.  Production of antibodies in transgenic plants , 1989, Nature.

[11]  P. Hogarth,et al.  FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. , 2002, Immunity.

[12]  P. Hwu,et al.  Recognition of human colon cancer by T cells transduced with a chimeric receptor gene , 2000, Cancer Gene Therapy.

[13]  P. Hogarth,et al.  FcγRI-Deficient Mice Show Multiple Alterations to Inflammatory and Immune Responses , 2002 .

[14]  P. Lerouge,et al.  Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Paris,et al.  The Destination for Single-Pass Membrane Proteins Is Influenced Markedly by the Length of the Hydrophobic Domain Article, publication date, and citation information can be found at www.plantcell.org/cgi/doi/10.1105/tpc.000620. , 2002, The Plant Cell Online.

[16]  T. Lehner,et al.  Generation and assembly of secretory antibodies in plants , 1995, Science.

[17]  M. Hulett,et al.  Molecular basis of Fc receptor function. , 1994, Advances in immunology.

[18]  S. Asurmendi,et al.  Coat protein regulates formation of replication complexes during tobacco mosaic virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Ko,et al.  Plant biopharming of monoclonal antibodies. , 2005, Virus research.

[20]  R. Schmidt,et al.  Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .